Low-dose computed tomographic screening has been found to reduce lung-cancer mortality. The effectiveness of this screening method is being explored in various studies, including a large veterans health administration study that may expand eligibility criteria. Research on low-dose ct screening also involves the use of imaging and biomarker advances, as well as artificial intelligence, to improve its effectiveness and efficiency.